AVP and COVID-19: Recent clinical studies, including our previously published work (Ciortea (2024) [13]; Petrea (2024) [81]), have highlighted the role of copeptin in pediatric patients with MIS-C and COVID-19, particularly due to the fact that SIADH may frequently occur in these patients through a non-osmotic ADH release mechanism triggered by inflammation and cytokine surge.